Skip to main content

Table 3 Schedule of assessments

From: Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

 

Baseline

4-6 wks

4 mth

8 mth

12 mth

16 mth

20 mth

24 mth

History

X

 

X

X

X

X

X

X

Body mass index/height cm

X

 

X

X

X

X

X

X

Serum corrected calcium

X

X

X

X

X

X

X

X

Phosphate

X

X

X

X

X

X

X

X

24 hour urinary calcium (preferred)

X

X

X

     

Urinary calcium/creatinine ratio

(for first 3 time points only if 24 h urine unavailable)

X

X

X

X

X

X

X

X

Serum

25O D

X

X

X

 

X

  

X

FBC

X

  

X

 

X

 

X

LFTs

X

  

X

 

X

 

X

eGFR

X

  

X

 

X

 

X

Adherence to dosing regime

X

 

X

X

X

X

X

X

Tumour status

X

 

X

X

X

X

X

X

  1. Note: Serum corrected calcium requires serum albumin.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us